First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up

Neuromuscular Disorders

Volumn 17, Issue 1, 2007, Pages 38-46

  Skuk, Daniel ^a   Goulet, Marlyne ^a   Roy, Brigitte ^a   Piette, Vincent ^a   Côté, Claude H ^a   Chapdelaine, Pierre ^a   Hogrel, Jean Yves ^b   Paradis, Martin ^a   Bouchard, Jean Pierre ^c   Sylvain, Michel ^a   Lachance, Jean Guy ^d   Tremblay, Jacques P ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b Institut de Myologie   (France)

^c LAVAL UNIVERSITY   (Canada)

^d Service de niphrologie   (Canada)

Author keywords

Cell transplantation; Clinical trial; Duchenne muscular dystrophy; Dystrophin; Muscle precursor cell; Tacrolimus

Indexed keywords

DYSTROPHIN; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DUCHENNE MUSCULAR DYSTROPHY; FOLLOW UP; GRAFT REJECTION; HIGH DENSITY INJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INJECTION; MALE; MUSCLE MASS; MUSCLE STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPLANTATION;

EID: 33846684514     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2006.10.003     Document Type: Article

References (25)

1. Moxley III R.T., Ashwal S., Pandya S., et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 64 (2005) 13-20
2. Do T. Orthopedic management of the muscular dystrophies. Curr Opin Pediatr 14 (2002) 50-53
3. Jeppesen J., Green A., Steffensen B.F., and Rahbek J. The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord 13 (2003) 804-812
4. Partridge T.A., Grounds M., and Sloper J.C. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 273 (1978) 306-308
5. Partridge T.A., Morgan J.E., Coulton G.R., Hoffman E.P., and Kunkel L.M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337 (1989) 176-179
6. Alameddine H.S., Louboutin J.P., Dehaupas M., Sebille A., and Fardeau M. Functional recovery induced by satellite cell grafts in irreversibly injured muscles. Cell Transplant 3 (1994) 3-14
7. Wernig A., Irintchev A., and Lange G. Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression. J Physiol (Lond) 484 (1995) 493-504
8. Skuk D., Roy B., Goulet M., et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 9 (2004) 475-482
9. Skuk D., Goulet M., Roy B., et al. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 65 (2006) 371-386
10. Kinoshita I., Vilquin J.T., Gravel C., Roy R., and Tremblay J.P. Myoblast allotransplantation in primates. Muscle Nerve 18 (1995) 1217-1218
11. Kinoshita I., Roy R., Dugre F.J., et al. Myoblast transplantation in monkeys: control of immune response by FK506. J Neuropathol Exp Neurol 55 (1996) 687-697
12. Skuk D., Roy B., Goulet M., and Tremblay J.P. Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp Neurol 155 (1999) 22-30
13. Skuk D., Goulet M., Roy B., and Tremblay J.P. Myoblast transplantation in whole muscle of nonhuman primates. J Neuropathol Exp Neurol 59 (2000) 197-206
14. Skuk D., Goulet M., Roy B., and Tremblay J.P. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Exp Neurol 175 (2002) 112-126
15. Belles-Isles M., Roy R., Dansereau G., et al. Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM. Eur J Histochem 37 (1993) 375-380
16. Skuk D, Goulet M, Tremblay JP. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic-cell injection procedure. Cell Transplant, in press.
17. Skuk D., and Tremblay J.P. "Engineering" myoblast transplantation. Graft 4 (2001) 558-570
18. Klein C.J., Coovert D.D., Bulman D.E., Ray P.N., Mendell J.R., and Burghes A.H. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 50 (1992) 950-959
19. Sharma K.R., Mynhier M.A., and Miller R.G. Cyclosporine increases muscular force generation in Duchenne muscular dystrophy. Neurology 43 (1993) 527-532
20. Skuk D., and Tremblay J.P. Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil 24 (2003) 285-300
21. Skuk D. Myoblast transplantation for inherited myopathies: a clinical approach. Expert Opin Biol Ther 4 (2004) 1871-1885
22. Sampaolesi M., Torrente Y., Innocenzi A., et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301 (2003) 487-492
23. Goyenvalle A., Vulin A., Fougerousse F., et al. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 306 (2004) 1796-1799
24. Gregorevic P., Blankinship M.J., Allen J.M., et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10 (2004) 828-834
25. Romero N.B., Braun S., Benveniste O., et al. Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy. Hum Gene Ther 15 (2004) 1065-1076